Don't want ads? Subscribe or login now.

Impax Settles With Daiichi, Genzyme Over Generic Welchol

By Jacqueline Bell · June 30, 2011, 12:27 PM EDT

Impax Laboratories Inc. said Thursday it had resolved patent litigation brought by Daiichi Sankyo Inc and Genzyme Corp. in Delaware over cholesterol drug Welchol, striking a deal that will allow Impax...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Daiichi Sankyo Inc. et al v. Impax Laboratories Inc.

Case Number

1:10-cv-00032

Court

Delaware

Nature of Suit

Patent

Date Filed

January 14, 2010

Recent Articles By Jacqueline

August 23, 2022
These Firms Have The Most Women In Equity Partnerships
August 22, 2022
A Deep Dive Into The Glass Ceiling Report: Women In Law
July 26, 2022
These Law Firms Have The Most Diverse Equity Partnerships
July 25, 2022
Law360's Diversity Snapshot: What You Need To Know
June 20, 2022
The Law360 400: Tracking The Largest US Law Firms
January 26, 2022
Justice Breyer To Retire From High Court
November 01, 2021
As Social Impact Becomes The Test, Firms Asked To Step Up
September 14, 2021
These Firms Have The Most Women In Equity Partnerships
September 13, 2021
Law360's Glass Ceiling Report: What You Need To Know
August 17, 2021
These Law Firms Have The Most Diverse Equity Partnerships